This combination tablet contains Glimepiride 2mg, Pioglitazone 15mg, and Metformin 500mg (Sustained Release), designed for the management of type 2 diabetes mellitus. Glimepiride: A sulfonylurea that stimulates insulin secretion from pancreatic beta-cells, helping control blood sugar levels. Pioglitazone: A thiazolidinedione that improves insulin sensitivity in muscle and adipose tissue. Metformin SR: A biguanide that reduces hepatic glucose production and improves peripheral glucose uptake. This triple-action formulation helps control blood glucose levels effectively, reducing the risk of diabetes-related complications. Sustained-release (SR) ensures once-daily dosing, improving patient adherence and minimizing gastrointestinal side effects.
